ABEONA THERAPEUTICS INC. — Investor Relations & Filings
Filings indexed
1,022
across all filing types
Latest filing
2026-02-12
Major Shareholding Noti…
Country
US
United States of America
Listing
US
ABEO
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company that develops cell and gene therapies for serious and life-threatening rare diseases. The company's pipeline targets a range of genetic disorders, including recessive dystrophic epidermolysis bullosa (RDEB) and various ophthalmic conditions such as X-linked retinoschisis, Stargardt disease, and autosomal dominant optic atrophy. Abeona also has partnered programs in early clinical development for Sanfilippo syndrome and Batten disease. The company operates its own manufacturing facility, The Elisa Linton Center for Rare Disease Therapies, to support the development of its therapeutic candidates.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-12 | English | |
| 4 - ABEONA THERAPEUTICS INC. (0000318306) (Filer) | 2026-02-04 | English | |
| 4 Filing | 2026-02-02 | English | |
| 4 Filing | 2026-02-02 | English | |
| 4 Filing | 2026-02-02 | English | |
| 4 Filing | 2026-02-02 | English |
Browse filings by year
21 years- 2026 38 filings
- 2025 88 filings
- 2024 84 filings
- 2023 65 filings
- 2022 57 filings
- 2021 85 filings
- 2020 77 filings
- 2019 66 filings
- 2018 38 filings
- 2017 35 filings
- 2016 44 filings
- 2015 62 filings
- 2014 32 filings
- 2013 12 filings
- 2012 36 filings
- 2011 20 filings
- 2010 44 filings
- 2009 22 filings
- 2008 56 filings
- 2007 37 filings
- 2006 24 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 23133541 | SCHEDULE 13G/A Filing | 2026-02-12 | English | ||
| 32879578 | 4 - ABEONA THERAPEUTICS INC. (0000318306) (Filer) | 2026-02-04 | English | ||
| 17940129 | 4 Filing | 2026-02-02 | English | ||
| 17940101 | 4 Filing | 2026-02-02 | English | ||
| 17940097 | 4 Filing | 2026-02-02 | English | ||
| 17940082 | 4 Filing | 2026-02-02 | English | ||
| 17940135 | 4 Filing | 2026-01-27 | English | ||
| 17940122 | 4 Filing | 2026-01-27 | English | ||
| 17940114 | 4 Filing | 2026-01-27 | English | ||
| 17940113 | 4 Filing | 2026-01-27 | English | ||
| 17940090 | 4 Filing | 2026-01-27 | English | ||
| 17940076 | 4 Filing | 2026-01-27 | English | ||
| 17940055 | 4 Filing | 2026-01-27 | English | ||
| 17940053 | 4 Filing | 2026-01-27 | English | ||
| 17940104 | 4 Filing | 2026-01-26 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ABEONA THERAPEUTICS INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33413/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33413 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33413 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33413 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33413}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ABEONA THERAPEUTICS INC. (id: 33413)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.